Phio Pharmaceuticals (PHIO) Times Interest Earned (2024 - 2025)
Phio Pharmaceuticals' (PHIO) quarterly Times Interest Earned came in at 25.86 in Q4 2025, down 272.66% quarter-over-quarter from 14.98 in Q1 2025.
Powered by 
Analysis
Phio Pharmaceuticals (PHIO) Times Interest Earned (2024 - 2025) Analysis & Trends
Phio Pharmaceuticals (PHIO) has reported Times Interest Earned for 2 consecutive years, with 25.86 the latest figure, recorded in Q4 2025.
- For the quarter ending Q4 2025, Times Interest Earned changed N/A year-over-year to 25.86; the trailing twelve-month figure through Dec 2025 stood at 94.08 (changed N/A YoY), and the FY2025 full-year result was 94.08, changed N/A from the prior year.
- Times Interest Earned declined to 25.86 in Q4 2025 per PHIO's latest filing, from 14.98 in the prior quarter.
- Across five years, Times Interest Earned topped out at 41.68 in Q1 2024 and bottomed at 25.86 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn | 5.22 |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn | -42.08 |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn | 117.59 |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn | 493.00 |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn | 2.82 |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn | - |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn | -0.08 |
| 10 | Phio Pharmaceuticals | 12.55 Mn | 12.55 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -25.86 |
| Mar 31, 2025 | 14.98 |
| Mar 31, 2024 | 41.68 |